NYSE - Delayed Quote • USD
Alcon Inc. (ALC)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 4:50 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,562,000.00
9,455,000.00
8,717,000.00
8,291,000.00
6,833,000.00
Cost of Revenue
4,238,000.00
4,208,000.00
3,969,000.00
3,639,000.00
3,893,000.00
Gross Profit
5,324,000.00
5,247,000.00
4,748,000.00
4,652,000.00
2,940,000.00
Operating Expense
4,185,000.00
4,208,000.00
4,076,000.00
4,072,000.00
3,422,000.00
Operating Income
1,139,000.00
1,039,000.00
672,000.00
580,000.00
-482,000.00
Net Non Operating Interest Income Expense
-133,000.00
-155,000.00
-130,000.00
-127,000.00
-127,000.00
Other Income Expense
--
-52,000.00
-79,000.00
-35,000.00
-26,000.00
Pretax Income
954,000.00
832,000.00
463,000.00
418,000.00
-635,000.00
Tax Provision
-94,000.00
-142,000.00
128,000.00
42,000.00
-104,000.00
Net Income Common Stockholders
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
Diluted NI Available to Com Stockholders
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
Basic EPS
2.13
--
0.68
0.77
-1.09
Diluted EPS
2.11
--
0.68
0.76
-1.09
Basic Average Shares
493,350.00
--
491,400.00
490,000.00
489,000.00
Diluted Average Shares
496,775.00
--
494,400.00
493,400.00
489,000.00
Total Operating Income as Reported
1,139,000.00
1,039,000.00
672,000.00
580,000.00
-482,000.00
Total Expenses
8,423,000.00
8,416,000.00
8,045,000.00
7,711,000.00
7,315,000.00
Net Income from Continuing & Discontinued Operation
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
Normalized Income
1,079,200.00
1,021,580.00
392,196.00
407,500.00
-509,264.00
Interest Income
--
45,000.00
16,000.00
3,000.00
6,000.00
Interest Expense
187,000.00
189,000.00
134,000.00
120,000.00
124,000.00
Net Interest Income
-133,000.00
-155,000.00
-130,000.00
-127,000.00
-127,000.00
EBIT
1,141,000.00
1,021,000.00
597,000.00
538,000.00
-511,000.00
EBITDA
2,356,000.00
2,242,000.00
1,720,000.00
1,757,000.00
1,112,000.00
Reconciled Cost of Revenue
4,238,000.00
4,208,000.00
3,969,000.00
3,639,000.00
3,893,000.00
Reconciled Depreciation
1,215,000.00
1,221,000.00
1,123,000.00
1,219,000.00
1,623,000.00
Net Income from Continuing Operation Net Minority Interest
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
Total Unusual Items Excluding Goodwill
-52,000.00
-52,000.00
-79,000.00
-35,000.00
-26,000.00
Total Unusual Items
-52,000.00
-52,000.00
-79,000.00
-35,000.00
-26,000.00
Normalized EBITDA
2,408,000.00
2,294,000.00
1,799,000.00
1,792,000.00
1,138,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-20,800.00
-4,420.00
-21,804.00
-3,500.00
-4,264.00
12/31/2020 - 4/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COO The Cooper Companies, Inc.
97.31
-0.60%
BLCO Bausch + Lomb Corporation
14.65
-3.87%
RMD ResMed Inc.
218.57
-0.64%
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
BDX Becton, Dickinson and Company
236.30
-0.14%
STVN Stevanato Group S.p.A.
20.71
-0.96%
BAX Baxter International Inc.
35.25
+0.23%
STAA STAAR Surgical Company
42.70
+0.19%
HOLX Hologic, Inc.
75.02
+0.09%
BLFS BioLife Solutions, Inc.
21.96
-0.05%